Nurami Medical
Hannoch Marksheid has a diverse work experience spanning multiple industries.
Hannoch started their career at Mati Ra'anana in 2000, where they served as VP until 2003.
In 2003, Marksheid joined B-Control as CEO and held the position until 2015.
Hannoch then moved on to BioCep in 2007, initially serving as CFO before taking on the role of CEO in 2009. Marksheid remained with BioCep until 2018 and also briefly worked as an advisor for the company in 2018.
Since 2018, Marksheid has been working as the CEO of Nurami Medical.
Hannoch Marksheid's education history includes a Bachelor of Arts degree in Economics from the University of Haifa, which they obtained from 1977 to 1980. Hannoch later pursued further studies at the University of West London, where they earned a Master's in Business Administration (MBA) in Strategic Management from 1996 to 1998.
This person is not in any offices
Nurami Medical
Nurami Medical is dedicated to the development of a surgical scaffold platform for the repair, regeneration and safe healing of soft tissues following internal surgeries. Nurami Medical production technology is based on the electrospinning technique.